// App-Quantinova.ai

TCT-500 : Prognostic Implications of Reduced Pre-procedural TIMI Flow in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing PCI

Researchers

Presenter

  • Mordechai Golomb

Principal Investigators

  • Rafal Wolny

  • Yangbo Liu

  • Patrick Serruys

  • Clemens von Birgelen

  • Pieter Smits

  • Bjorn Redfors

  • Mahesh Madhavan

  • Ori Ben-Yehuda

  • Roxana Mehran

  • Martin Leon

  • Gregg Stone

Medical Centers

  • Cardiovascular Research Foundation, New York, New York, United States

  • Institute of Cardiology, Warsaw, Poland

  • Maasstad Ziekenhuis, Rotterdam, Netherlands

  • NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York, United States

  • Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Thoraxcentrum Twente, Enschede, Netherlands

  • Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, New York, United States

  • Imperial College, London, United Kingdom

Locations

  • United States

  • Poland

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Angina

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A